Compare KRRO & ICG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRRO | ICG |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.1M | 97.1M |
| IPO Year | N/A | N/A |
| Metric | KRRO | ICG |
|---|---|---|
| Price | $11.63 | $1.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 1 |
| Target Price | ★ $54.60 | $7.50 |
| AVG Volume (30 Days) | ★ 294.9K | 62.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $145.97 | N/A |
| Revenue Next Year | N/A | $75.98 |
| P/E Ratio | ★ N/A | $7.32 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.20 | $0.93 |
| 52 Week High | $55.89 | $4.19 |
| Indicator | KRRO | ICG |
|---|---|---|
| Relative Strength Index (RSI) | 51.81 | 34.67 |
| Support Level | $10.81 | $1.41 |
| Resistance Level | $12.46 | $1.79 |
| Average True Range (ATR) | 1.11 | 0.16 |
| MACD | -0.12 | -0.06 |
| Stochastic Oscillator | 16.69 | 7.76 |
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.